Daniel Au, MD
I believe in collaborative care with my patients. Medical treatment is a process that must fit within the lives, goals, and priorities of patients. It is important to me that my patients both understand their conditions and treatment options and are comfortable with their choice of treatment we develop together.
Dr. Au was drawn to Urology in medical school when he recognized it as a field known for implementing cutting edge science and technology to further the care of patients as well as being a field centered around quality-of-life issues. Dr. Au loves that as a surgeon, he can follow in this tradition and both deliver tangible solutions to his patients and maintain a continuity of care unique within surgical specialties.
Dr. Au specializes in minimally invasive robotic surgery for benign and oncologic conditions, Holmium Laser Enucleation of the Prostate (HoLEP), a procedure for benign prostate hyperplasia (BPH), and kidney stone disease treatments. He received his training at the University of Kansas, which is known for extensive training in urologic oncology, robotic surgery, and advanced laser BPH and stone surgery.
Dr. Au enjoys providing patients with the education to understand their conditions and care plans. He believes the best part of his work is guiding patients through the complex information of modern medicine to create a shared treatment plan.
Dr. Au loves the outdoors and the many options that living in the Portland metro area affords to appreciate the natural beauty of the Pacific Northwest. Outside of work, Dr. Au enjoys cooking, travelling, photography, baseball, and exploring the mountains and forests of the Pacific Northwest.
- Residency, University of Kansas Medical Center, Kansas City, KS, 2022
- MD, Saint Louis University School of Medicine, Saint Louis, MO, 2017
- BA, University of California Los Angeles, Los Angeles, CA, 2009
- Au D, Lee E, Popoola T, et al. Factors Associated with Utilization of Neoadjuvant Chemotherapy in Charlson Comorbidity Zero Non-Metastatic Muscle-Invasive Bladder Cancer Patients. International Brazilian Journal of Urology. Vol 47. No 4:803-818. July/Aug 2021.
- May D, Smelser W, Au D, Holzbeierlein J. AUA Update Series Lesson on The Incidental Adrenal Mass: Diagnosis and Treatment. March 2021.
- May A, Henke J, Au D, et al. National trends in the Utilization of Androgen Deprivation Therapy for Very Low Risk Prostate Cancer. Urology. Vol 130:79-85. August 2019.
- Member, American Urological Association